Natera (NTRA) Receives Daily Coverage Optimism Rating of -0.04

Press coverage about Natera (NASDAQ:NTRA) has been trending somewhat negative on Friday, according to AlphaOne. AlphaOne, a subsidiary of Accern, rates the sentiment of news coverage by reviewing more than twenty million blog and news sources. AlphaOne ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Natera earned a news sentiment score of -0.04 on AlphaOne’s scale. AlphaOne also assigned media headlines about the medical research company an impact score of 0 out of 100, meaning that recent news coverage is extremely unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the media headlines that may have impacted AlphaOne’s rankings:

Insider Buying and Selling by Quarter for Natera (NASDAQ:NTRA)

Natera (NASDAQ:NTRA) traded down 0.67% during mid-day trading on Friday, hitting $10.45. 411,891 shares of the stock were exchanged. The company’s market capitalization is $552.62 million. The stock’s 50-day moving average is $10.15 and its 200 day moving average is $9.90. Natera has a 52 week low of $7.35 and a 52 week high of $13.74.

Natera (NASDAQ:NTRA) last released its quarterly earnings results on Tuesday, May 9th. The medical research company reported ($0.70) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.61) by $0.09. The firm had revenue of $46.90 million for the quarter, compared to the consensus estimate of $42.82 million. Natera had a negative net margin of 60.89% and a negative return on equity of 101.63%. The company’s revenue for the quarter was down 24.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.17) earnings per share. On average, analysts anticipate that Natera will post ($1.96) EPS for the current year.

A number of research firms recently weighed in on NTRA. Zacks Investment Research downgraded shares of Natera from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Cowen and Company cut their price target on shares of Natera from $17.00 to $14.00 and set an “outperform” rating for the company in a research note on Tuesday, March 14th. Finally, Canaccord Genuity increased their price target on shares of Natera from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Wednesday, May 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $16.20.

ILLEGAL ACTIVITY NOTICE: “Natera (NTRA) Receives Daily Coverage Optimism Rating of -0.04” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at

About Natera

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply